Antares Pharma, Inc. ATRS

Set alert

Price alert · ATRS

All alert types
5.59 0.00 0.00%

As of Apr 24, 3:47 PM ET

5.58 Day range 5.59

52-week range unavailable

Open
5.59
Prev close
5.59
Mkt cap
955.06M
Vol
1.76M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
5.58
High
5.59
Forward P/E
25.41
Beta
1.15
Short ratio
0.41
Inst. own
62.83%
Dividend
0.00
Ex-div date
Earnings
May 10, 2022
50-d avg
4.90
200-d avg
3.92
1y target
5.95

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for ATRS has not been loaded yet. Try again in a moment.

Valuation

P/E 13.2×
FY 2012: -38.1×FY 2013: -27.9×FY 2014: -9.5×FY 2015: -8.6×FY 2016: -14.6×FY 2017: -18.1×FY 2018: -68.0×FY 2019: -470×FY 2020: 12.1×FY 2021: 13.2×
FY 2012 5y median -18.1× FY 2021
P/S 3.3×
FY 2012: 18.6×FY 2013: 27.5×FY 2014: 12.7×FY 2015: 3.9×FY 2016: 6.9×FY 2017: 5.7×FY 2018: 7.0×FY 2019: 7.7×FY 2020: 4.5×FY 2021: 3.3×
FY 2012 5y median 5.7× FY 2021
P/B 3.5×
FY 2012: 4.9×FY 2013: 8.0×FY 2014: 8.1×FY 2015: 2.6×FY 2016: 8.0×FY 2017: 9.3×FY 2018: 11.4×FY 2019: 17.5×FY 2020: 5.7×FY 2021: 3.5×
FY 2012 5y median 9.3× FY 2021
P/FCF 20.2×
FY 2012: -30.0×FY 2013: -31.3×FY 2014: -10.5×FY 2015: -5.1×FY 2016: -17.9×FY 2017: -12.7×FY 2018: -24.3×FY 2019: -73.5×FY 2020: 101×FY 2021: 20.2×
FY 2012 5y median -12.7× FY 2021
EV/EBITDA 8.5×
FY 2012: -32.8×FY 2013: -26.1×FY 2014: -8.9×FY 2015: -7.6×FY 2016: -14.9×FY 2017: -23.4×FY 2018: -394×FY 2019: 238×FY 2020: 40.9×FY 2021: 8.5×
FY 2012 5y median 8.5× FY 2021
EV/Sales 3.1×
FY 2012: 16.3×FY 2013: 25.6×FY 2014: 11.4×FY 2015: 3.2×FY 2016: 6.4×FY 2017: 5.7×FY 2018: 6.9×FY 2019: 7.8×FY 2020: 4.5×FY 2021: 3.1×
FY 2012 5y median 5.7× FY 2021
FCF Yield 4.9%
FY 2012: -3.3%FY 2013: -3.2%FY 2014: -9.5%FY 2015: -19.7%FY 2016: -5.6%FY 2017: -7.8%FY 2018: -4.1%FY 2019: -1.4%FY 2020: 1.0%FY 2021: 4.9%
FY 2012 5y median -1.4% FY 2021

Profitability

Gross Margin 62.9%
FY 2012: 57.8%FY 2013: 55.4%FY 2014: 57.6%FY 2015: 57.4%FY 2016: 44.8%FY 2017: 49.6%FY 2018: 51.1%FY 2019: 59.2%FY 2020: 57.8%FY 2021: 62.9%
FY 2012 5y median 57.8% FY 2021
Operating Margin 33.8%
FY 2012: -50.7%FY 2013: -101.1%FY 2014: -132.5%FY 2015: -44.8%FY 2016: -46.2%FY 2017: -30.2%FY 2018: -6.5%FY 2019: 0.8%FY 2020: 9.1%FY 2021: 33.8%
FY 2012 5y median 0.8% FY 2021
Net Margin 25.2%
FY 2012: -50.6%FY 2013: -99.5%FY 2014: -132.6%FY 2015: -45.2%FY 2016: -46.6%FY 2017: -30.7%FY 2018: -10.3%FY 2019: -1.6%FY 2020: 37.6%FY 2021: 25.2%
FY 2012 5y median -1.6% FY 2021
ROE 26.3%
FY 2012: -13.2%FY 2013: -29.0%FY 2014: -85.3%FY 2015: -30.8%FY 2016: -53.8%FY 2017: -49.9%FY 2018: -16.7%FY 2019: -3.7%FY 2020: 47.2%FY 2021: 26.3%
FY 2012 5y median -3.7% FY 2021
ROIC 25.0%
FY 2012: -13.1%FY 2013: -28.3%FY 2014: -78.8%FY 2015: -30.2%FY 2016: -52.0%FY 2017: -28.1%FY 2018: -6.4%FY 2019: 1.0%FY 2020: 8.2%FY 2021: 25.0%
FY 2012 5y median 1.0% FY 2021
ROA 18.0%
FY 2012: -12.0%FY 2013: -23.1%FY 2014: -51.1%FY 2015: -24.4%FY 2016: -36.7%FY 2017: -22.5%FY 2018: -7.4%FY 2019: -1.5%FY 2020: 26.4%FY 2021: 18.0%
FY 2012 5y median -1.5% FY 2021

Growth (YoY)

Revenue 23.0%
FY 2012: 37.2%FY 2013: -8.7%FY 2014: 28.5%FY 2015: 72.3%FY 2016: 14.4%FY 2017: 4.4%FY 2018: 16.6%FY 2019: 94.9%FY 2020: 20.8%FY 2021: 23.0%
FY 2012 FY 2021
Operating Income 357.2%
FY 2012: -158.1%FY 2013: -82.1%FY 2014: -68.4%FY 2015: 41.7%FY 2016: -17.9%FY 2017: 31.8%FY 2018: 75.1%FY 2019: 124.2%FY 2020: 1272.9%FY 2021: 357.2%
FY 2012 FY 2021
EPS (diluted) -18.2%
FY 2012: -121.2%FY 2013: -60.0%FY 2014: -68.8%FY 2015: 48.1%FY 2016: -14.3%FY 2017: 31.3%FY 2018: 63.6%FY 2019: 75.0%FY 2020: 3400.0%FY 2021: -18.2%
FY 2012 FY 2021
Free Cash Flow 347.5%
FY 2012: -457.2%FY 2013: -29.7%FY 2014: -76.4%FY 2015: -9.1%FY 2016: 42.1%FY 2017: -20.6%FY 2018: 25.2%FY 2019: 28.8%FY 2020: 151.7%FY 2021: 347.5%
FY 2012 FY 2021

Financial Health

Current Ratio 2.7×
FY 2012: 9.8×FY 2013: 4.4×FY 2014: 2.2×FY 2015: 3.9×FY 2016: 2.3×FY 2017: 3.5×FY 2018: 2.6×FY 2019: 3.3×FY 2020: 2.0×FY 2021: 2.7×
FY 2012 5y median 2.7× FY 2021
Quick Ratio 2.5×
FY 2012: 9.7×FY 2013: 4.0×FY 2014: 2.0×FY 2015: 3.6×FY 2016: 2.0×FY 2017: 2.9×FY 2018: 2.2×FY 2019: 2.9×FY 2020: 1.7×FY 2021: 2.5×
FY 2012 5y median 2.5× FY 2021
Debt / Equity 0.1×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: 0.7×FY 2018: 0.6×FY 2019: 0.8×FY 2020: 0.4×FY 2021: 0.1×
FY 2012 5y median 0.6× FY 2021
Net Debt / EBITDA -0.6×
FY 2012: 4.7×FY 2013: 1.9×FY 2014: 1.0×FY 2015: 1.7×FY 2016: 1.2×FY 2017: 0.1×FY 2018: 2.5×FY 2019: 4.5×FY 2020: -0.7×FY 2021: -0.6×
FY 2012 5y median 0.1× FY 2021
Interest Coverage 0.0×
FY 2012: 0.0×FY 2013: 0.0×FY 2014: 0.0×FY 2015: 0.0×FY 2016: 0.0×FY 2017: -11.6×FY 2018: -1.5×FY 2019: 0.3×FY 2020: 3.6×FY 2021: 0.0×
FY 2012 5y median 0.0× FY 2021

Dividends

Dividend Yield 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2012: 0.0%FY 2013: 0.0%FY 2014: 0.0%FY 2015: 0.0%FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2012 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31